Medical Developments (ASX: MVP) — Perfil da empresa, notícias e dados financeiros
Medical Developments is a specialised healthcare company that manufactures and distributes emergency pain management treatments and respiratory medical devices.
Medical Developments
Medical Developments is a specialised healthcare company that manufactures and distributes emergency pain management treatments and respiratory medical devices. The company's flagship product, Penthrox, commonly known as the Green Whistle, is a handheld, non-opioid inhalable analgesic used for the rapid relief of acute trauma and procedural pain. In addition to its acute pain portfolio, the business manufactures and supplies asthma and chronic obstructive pulmonary disease management products, including valved holding chambers, spacers, and peak flow meters. The company supplies emergency services, hospitals, dental clinics, and pharmacy networks across Australia, Europe, North America, and international markets.
Resumo
Operações
Produtos e/ou serviços de Medical Developments
- Acute Pain Analgesics: Manufacturing and marketing fast-acting non-opioid inhalable analgesics designed for patient self-administration to relieve trauma and procedural pain across emergency medical care, emergency service response, defense forces, dental clinics, and hospital departments.
- Asthma and COPD Spacers: Producing valved holding chambers and asthma space devices engineered to maximize pulmonary aerosol medication deposition while minimizing oropharyngeal deposition for pediatric, adolescent, and adult respiratory patients across hospital and pharmacy channels.
- Respiratory Diagnostic Equipment: Supplying peak flow meters and respiratory monitoring instruments that measure peak expiratory flow rates, enabling healthcare providers and patients to track pulmonary lung function and evaluate asthma treatment effectiveness.
- Emergency Resuscitation Products: Manufacturing emergency medical resuscitation devices, portable oxygen therapy units, and aspiration equipment used by emergency medical technicians, paramedics, and trauma treatment teams during acute clinical interventions.
- International Distribution Partnerships: Expanding global market footprint through commercial licensing agreements with regional pharmaceutical companies to secure regulatory approvals and distribute specialized emergency pain relief treatments across European, North American, and Asian markets.
- Contract Manufacturing Operations: Providing continuous-flow chemical synthesis, pharmaceutical packaging, and precision plastic injection moulding services for external healthcare customers utilizing specialized Australian production facilities and regulatory-compliant infrastructure.
equipe executiva do Medical Developments
- Brent MacGregorChief Executive Officer
- Anita JamesChief Financial Officer
- Anastasia TanHead of Operations & Supply Chain
- Wayne PearceHead of Production
- Julianne AlexanderHead of Medical Affairs, Regulatory Affairs & Clinical Development
- Benson LeeHead of Commercial Operations
- Victoria SowemimoHead of Quality
Últimas notícias sobre a Medical Developments
Comunicados recentes
O que a Medical Developments (MVP) comunicou ao mercado, do mais recente para o mais antigo.
- Corporate Governance Statement 2026
- Notice of Annual General Meeting 2026
- Annual Report 2026
- Appendix 4G 2026
Histórico de dividendos
Dividendos por ação pagos pela Medical Developments, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2020 | A$0.0192 | A$0.0192 | — | A$0.0383 |
| FY2019 | A$0.0192 | A$0.0192 | — | A$0.0383 |
| FY2018 | A$0.0192 | A$0.0192 | — | A$0.0383 |
| FY2017 | A$0.0192 | A$0.0192 | — | A$0.0383 |
| FY2016 | — | A$0.0192 | — | A$0.0192 |
Principais indicadores financeiros
Resultados divulgados pela Medical Developments, em AUD.
- Cap. de mercado
- 41,1 mi
- Receita (TTM)
- 42,6 mi
- P/L
- 36.5
- LPA (diluído, TTM)
- 0.0
- Dividend yield
- —
- Margem de lucro
- 1.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 42,6 mi | 1,1 mi | 626 mil | |
| 39,1 mi | 3,1 mi | 94 mil | |
| 33,1 mi | -16,9 mi | -41 mi | |
| 32,3 mi | -20,4 mi | -5,6 mi |